Skip to main content
. 2018 Nov 13;2(21):3012–3024. doi: 10.1182/bloodadvances.2018020065

Figure 1.

Figure 1.

Analysis of HDAC6 expression in CLL patient samples. (A) Intracellular HDAC6 protein expression in CD19+ CD5− B cells from normal donors (n = 13) and CD19+ CD5+ B cells from CLL patient peripheral blood samples (n = 38), as determined by flow cytometry. (B) Correlation analyses showing relationship between HDAC6 protein expression and CLL B-cell percentages in CLL patient samples. (C) HDAC6 protein expression in CD38+ or CD38− CLL patient samples. Error bars correspond to standard deviations. *P < .05, **P < .005. MFIR, median fluorescence intensity ratio (value normalized to isotype control).